Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason K Russell

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 7, 2025
Brain cholinergic terminal density utilizing [<sup>18</sup>F]-fluoroethoxybenzovesamicol PET in adults with Down's syndrome: Relationship to amyloid PET and cognitive performanceJason K Russell, Alexander C Conley, Brian D Boyd, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersJason K Russell, Alexander C Conley, Brian Boyd, et al.
Neurobiology of Aging|February 6, 2025
Differences in cholinergic terminal density in adults with Down syndrome compared to neurotypical controls measured by [<sup>18</sup>F]-fluoroethoxybenzovesamicol positron emission tomography imagingJason K Russell, Alexander C Conley, Brian D Boyd, et al.
Medrxiv : the Preprint Server for Health Sciences|November 22, 2024
Age-Related Changes in the Cholinergic System in Adults with Down Syndrome Assessed Using [<sup>18</sup>F]-Fluoroethoxybenzovesamicol Positron Emission Tomography ImagingJason K Russell, Alexander C Conley, Brian D Boyd, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 7, 2025
Brain cholinergic terminal density utilizing [<sup>18</sup>F]-fluoroethoxybenzovesamicol PET in adults with Down's syndrome: Relationship to amyloid PET and cognitive performanceJason K Russell, Alexander C Conley, Brian D Boyd, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersJason K Russell, Alexander C Conley, Brian Boyd, et al.
Neurobiology of Aging|February 6, 2025
Differences in cholinergic terminal density in adults with Down syndrome compared to neurotypical controls measured by [<sup>18</sup>F]-fluoroethoxybenzovesamicol positron emission tomography imagingJason K Russell, Alexander C Conley, Brian D Boyd, et al.
Medrxiv : the Preprint Server for Health Sciences|November 22, 2024
Age-Related Changes in the Cholinergic System in Adults with Down Syndrome Assessed Using [<sup>18</sup>F]-Fluoroethoxybenzovesamicol Positron Emission Tomography ImagingJason K Russell, Alexander C Conley, Brian D Boyd, et al.
Pageof 2